Latest stories on SDGR
Schrodinger reports inducement grants under Nasdaq listing rule
The Fly50 · neutralgeneral
Schrödinger to Announce Third Quarter 2026 Financial Results on November 4
StockTitan50 · neutralgeneral
Schrodinger price target raised to $21 from $19 at UBS
The Fly64 · neutralanalyst
Schrodinger price target raised to $32 from $20 at KeyBanc
The Fly67 · bullishanalyst
Schrodinger price target raised to $31 from $20 at TD Cowen
The Fly67 · bullishanalyst
Schrodinger price target raised to $30 from $24 at BMO Capital
The Fly64 · neutralanalyst
These ten healthcare stocks posted the biggest September gains
Seeking Alpha64 · neutralgeneral
Schrodinger Stock Has Technical Strength as It Hits New 2-Year Highs
Barchart63 · neutralgeneral
Schrödinger: Company Creation Is Now The Real Drug Business
Seeking Alpha63 · neutralearnings
Schrödinger, Inc. (SDGR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha55 · neutralgeneral
Schrödinger jumps 12% to new 52-week high amid AI drug-discovery interest
Seeking Alpha73 · bullishproduct/pr
Schrodinger announces licensing, collaboration agreement with Tectora
The Fly63 · neutralproduct/pr
Schrodinger: The Software Business Is Stronger Than It Looks
Seeking Alpha63 · neutralproduct/pr
Schrodinger assumed with a Neutral at UBS
The Fly50 · neutralanalyst
UBS initiates Schrodinger stock coverage with neutral rating
Investing.com Analyst Ratings50 · neutralanalyst
Schrödinger (SDGR) Q2 2026 Earnings Call Transcript
The Motley Fool56 · neutralearnings
Schrödinger outlines 10%-15% 2026 ACV growth as Bristol Myers Squibb deploys Bunsen
Seeking Alpha63 · neutralproduct/pr
Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Schrodinger, Inc. (SDGR) files 8-K
SEC 8-K50 · neutralgeneral
Schrödinger expands Bristol Myers Squibb partnership with AI co-scientist deal
Seeking Alpha67 · bullishproduct/pr
Schrodinger: A Rare AI-Adjacent Disruptor Still Not Priced For It
Seeking Alpha67 · bullishproduct/pr
Schrödinger: Surviving, If Not Thriving, In The Tricky AI Drug Discovery Field
Seeking Alpha52 · neutralgeneral
Schrödinger Gains $57 Million From Ajax Acquisition Deal
TipRanks63 · neutralm&a
Schrodinger, Inc. (SDGR) files 8-K
SEC 8-K50 · neutralgeneral